Fuse Biotherapeutics Raises an Oversubscribed and Upsized Seed Financing Round of $9.5 Million LOS ANGELES, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Fuse Biotherapeutics, a company focused on developing next generation immune modulating therapeutics that directs and potentiates both innate and...